MedTrace Logo

Feasibility and Reliability of Multimodal Evoked Potentials

NCT03686826 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2019-01-23

No results posted yet for this study

Summary

Multimodal Evoked potentials (mmEP) reflect disease course of multiple sclerosis (MS) and are potentially suited as a biomarker for disease progression.

The acquisition of evoked potentials (EP) in this observatory trial is to evaluate the feasibility and test-retest reliability of motor and somato-sensory EP (MEP and SSEP) in an international multicenter setting in healthy subjects and subjects with multiple sclerosis (MS).

Conditions

Interventions

PROCEDURE

Acquisition of MEP und SSEP

Acquisition of MEP und SSEP at two different time points within 1 to 30 days

Sponsors & Collaborators

  • University Hospital, Basel, Switzerland

    lead OTHER

Principal Investigators

  • Peter Fuhr, Prof. Dr. MD · University Hospital Basel; Department of Neurology

Eligibility

Min Age
18 Years
Max Age
58 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-09-06
Primary Completion
2017-09-15
Completion
2018-12-31

Countries

  • Switzerland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03686826 on ClinicalTrials.gov